RxDoctor Payments Data

Charles Gordon, MD

Orthopaedic Surgery of the Spine · Daphne, ALNPI 1275825135

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $148,500 of the $208,378 with a category attached, or 71.3%. 43 manufacturers reported payments, led by 4web, Inc. at 47.7% of the total. Reporting peaked in 2022 at $66,673 and has fallen 89.3% since, to $7,122 in 2025.

$208,378in general payments, 2019–2025

Across 507 payments — averaging $411.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • 4web, Inc.$99K
  • Royal Biologics, Inc.$21K
  • Ulrich Medical USA, Inc.$18K
  • Seaspine Orthopedics Corporation$11K
  • Stryker$11K
  • Integrity Implants Inc.$11K
  • plus $37K from 37 others
$20,120in research payments, 2019–2025

Across 3 payments — averaging $6706.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$20K

What the payments were for

  • Royalty or licence$6,1393%
  • Consulting fees$148,50071%
  • Speaking & faculty fees$3,2402%
  • Travel & lodging$27,96113%
  • Food & beverage$22,17411%
  • Education$3410%
  • Entertainment$220%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$208,378 in reported general payments places this provider in the 75th percentile of 20 orthopaedic surgery of the spine providers in Alabama.

See all orthopaedic surgery of the spine providers in Alabama

Medicare billing

Part B allowed, 2024
$220,092
Medicare patients
168
Services billed
1,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MovantikNaloxegol Oxalate21$8,972
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen367$8,609
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen412$7,733
Pregabalin496$6,303
Gabapentin381$4,095
Xtampza ErOxycodone Myristate11$3,119
Tramadol Hcl353$2,997
Lidocaine20$1,846
Cyclobenzaprine Hcl209$1,822
Diclofenac Sodium78$1,451
Tizanidine Hcl156$1,424
Celecoxib97$1,213
Naloxone Hcl12$827
Duloxetine Hcl59$728
Baclofen52$515

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Daphne

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →